Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Decreasing Function01:27

Decreasing Function

312
A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
312
Glial Cells01:04

Glial Cells

94.4K
Overview
94.4K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

241
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

679
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
679
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

814
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
814
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

340
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
340

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemostatic efficacy of a novel Ca/P/S-based bone graft material and its preliminary clinical evidence in sternum closure procedures.

Frontiers in bioengineering and biotechnology·2026
Same author

Reassessing the risk-modifying effects of novel antidiabetic agents on asthma-COPD overlap syndrome: a dose-stratified network meta-analysis of 316,832 adults from 128 randomised trials.

EClinicalMedicine·2026
Same author

Real-world effectiveness of monoclonal antibody lecanemab versus acetylcholinesterase inhibitors in Alzheimer's disease: a target trial emulation.

Alzheimer's research & therapy·2026
Same author

Association of Esketamine use with mortality and clinical outcomes in patients with cancer-related depression: A target trial emulation.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Audiovestibular Dysfunction in Alcohol Use Disorder: A Systematic Review of Human Primary Clinical Evidence.

International journal of molecular sciences·2026
Same author

Differential Acute Kidney Injury Profiles of GLP-1RAs and SGLT2is: A Network Meta-Analysis.

International journal of molecular sciences·2026
Same journal

Understanding the physiological and psychological consequences of the GABAergic system in major depressive disorder.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Maternal folic acid modulates neurotrophins and behavior in an animal schizophrenia model.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Single Ayahuasca administration attenuates alcohol relapse and associated behavioral, neurochemical, and oxidative alterations in rats.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Altered dorsal striatal subregional connectivity associated with distinct executive function deficits in first-episode, drug-naïve major depressive disorder: Evidence from functional connectivity and granger causality analysis.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Chronic pain and stress: unravelling the common neuroinflammatory, immune and endocrine mechanisms for novel therapeutic approaches.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Predicting anhedonia and negative cognitive processing changes after 8-week SSRIs treatment in depression from individual differential structural covariance network.

Progress in neuro-psychopharmacology & biological psychiatry·2026
See all related articles

Related Experiment Video

Updated: Feb 14, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K

Age-associated decrease in serum glial cell line-derived neurotrophic factor levels in patients with major depressive

Ping-Tao Tseng1, Yu Lee, Pao-Yen Lin

  • 1Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, [corrected] Kaohsiung, Taiwan.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|October 2, 2012
PubMed
Summary
This summary is machine-generated.

Serum glial cell line-derived neurotrophic factor (GDNF) levels are lower in major depressive disorder (MDD) patients, particularly in older adults. This suggests GDNF may serve as a biomarker and therapeutic target for depression.

More Related Videos

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.5K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K

Related Experiment Videos

Last Updated: Feb 14, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.5K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biochemistry

Background:

  • The neurotrophic hypothesis is implicated in mood disorder pathophysiology.
  • Glial cell line-derived neurotrophic factor (GDNF) is a key neurotrophic factor.
  • Investigating GDNF in major depressive disorder (MDD) is crucial.

Purpose of the Study:

  • To examine serum GDNF levels in MDD patients across different disease states.
  • To compare GDNF levels between MDD patients and healthy controls.
  • To explore the relationship between GDNF levels and age in MDD.

Main Methods:

  • Serum GDNF levels measured using ELISA in 55 MDD patients and 35 controls.
  • MDD severity assessed via Hamilton Rating Scale of Depression (HAM-D).
  • Patients categorized into severe (HAM-D ≥ 19) and remitted (HAM-D ≤ 7) groups.

Main Results:

  • MDD patients exhibited significantly lower serum GDNF than controls (p<0.001).
  • Age-dependent reduction in GDNF observed in middle-aged and older adults, but not younger adults.
  • No significant difference in GDNF levels between severe and remitted MDD patients.

Conclusions:

  • Serum GDNF levels are reduced in MDD, with an age-associated decline.
  • GDNF may function as a disease marker for MDD.
  • GDNF presents a potential therapeutic target for novel antidepressant treatments.